Radiology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Published online before print November 22, 2005, 10.1148/radiol.2381041765
This Article
Right arrow Abstract Freely available
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Asayama, Y.
Right arrow Articles by Honda, H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Asayama, Y.
Right arrow Articles by Honda, H.

Delayed-Phase Dynamic CT Enhancement as a Prognostic Factor for Mass-forming Intrahepatic Cholangiocarcinoma1

Yoshiki Asayama, MD, Kengo Yoshimitsu, MD, Hiroyuki Irie, MD, Tsuyoshi Tajima, MD, Akihiro Nishie, MD, Masakazu Hirakawa, MD, Tomohiro Nakayama, MD, Daisuke Kakihara, MD, Akinobu Taketomi, MD, Shin-ichi Aishima, MD and Hiroshi Honda, MD

1 From the Departments of Clinical Radiology (Y.A., K.Y., H.I., T.T., A.N., M.H., T.N., D.K., H.H.), Surgery and Science (A.T.), and Anatomic Pathology (S.A.), Graduate School of Medical Sciences, Kyushu University, 3-1-1 Maidashi, Higashi-ku, Fukuoka 812-8582, Japan. From the 2004 RSNA Annual Meeting. Received October 13, 2004; revision requested December 22; revision received January 27, 2005; accepted February 28; final version accepted March 18. Address correspondence to Y.A. (e-mail: asayama{at}radiol.med.kyushu-u.ac.jp).



View larger version (162K):

[in a new window]
 
Figure 1a: Transverse CT scans in a 67-year-old man with ICC. (a) Scan obtained 45 seconds after the administration of contrast material shows early peripheral enhancement of the tumor (arrows). (b) Scan obtained 300 seconds after the injection of contrast material shows progressive and concentric filling. Because more than two-thirds of the tumor showed delayed enhancement, the patient was placed in group 1. A pathology specimen (not shown) obtained from the area of delayed enhancement exhibited a cluster of carcinoma cells with abundant fibrous stroma accompanied by inflammatory cell infiltration.

 


View larger version (160K):

[in a new window]
 
Figure 1b: Transverse CT scans in a 67-year-old man with ICC. (a) Scan obtained 45 seconds after the administration of contrast material shows early peripheral enhancement of the tumor (arrows). (b) Scan obtained 300 seconds after the injection of contrast material shows progressive and concentric filling. Because more than two-thirds of the tumor showed delayed enhancement, the patient was placed in group 1. A pathology specimen (not shown) obtained from the area of delayed enhancement exhibited a cluster of carcinoma cells with abundant fibrous stroma accompanied by inflammatory cell infiltration.

 


View larger version (132K):

[in a new window]
 
Figure 2a: Transverse CT scans in a 57-year-old woman with ICC in the right lobe of the liver. (a) Scan obtained 60 seconds after the administration of contrast material shows early enhancement of most of the tumor (arrows). (b) Scan obtained 300 seconds after the injection of contrast material shows washout of contrast material. Because less than two-thirds of the tumor showed delayed enhancement, the patient was placed in group 2.

 


View larger version (91K):

[in a new window]
 
Figure 2b: Transverse CT scans in a 57-year-old woman with ICC in the right lobe of the liver. (a) Scan obtained 60 seconds after the administration of contrast material shows early enhancement of most of the tumor (arrows). (b) Scan obtained 300 seconds after the injection of contrast material shows washout of contrast material. Because less than two-thirds of the tumor showed delayed enhancement, the patient was placed in group 2.

 


View larger version (25K):

[in a new window]
 
Figure 3: Graph shows survival curves for groups 1 and 2. The survival rate of patients in group 1 was significantly poorer than that in group 2.

 





HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
RADIOLOGY RADIOGRAPHICS RSNA JOURNALS ONLINE
Copyright © 2005 by the Radiological Society of North America.